Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 10Myelodysplastic Syndromes 4Mycoses 4Hematologic Neoplasms 4Leukemia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Neoplasm, Residual 1Myelodysplastic-Myeloproliferative Diseases 1Mucormycosis 1Leukemia, Myeloid 1Invasive Fungal Infections 1Genetic Predisposition to Disease 1Candidiasis 1Bronchiolitis Obliterans Syndrome 1Bone Marrow Neoplasms 1Bone Marrow Failure Disorders 1Aspergillosis 1Anemia, Aplastic 1

Interventions

Voriconazole 4liposomal amphotericin B 2Amphotericin B 2posaconazole 1isavuconazole 1Solutions 1Micafungin 1Itraconazole 1Fluconazole 1Caspofungin 1Blood Specimen Collection 1Anidulafungin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Invasive Fungal Infections × posaconazole × Other hematologic neoplasm × Clear all
NCT00750737 2016-09-29

Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)

M.D. Anderson Cancer Center

Phase 3 Completed
46 enrolled 6 charts
Other hematologic neoplasm

Invasive Fungal Infections, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡